Middlefield Healthcare Dividend ETFTSX:MHCD
- LAST PRICE11.29
- TODAY'S CHANGE (%)0.01 (0.09%)
- Bid / Lots11.25/ 10
- Ask / Lots11.36/ 10
- Open / Previous Close11.29 / 11.28
- Day Range
- 52 Week Range
- Volume2,670
- Overall Morningstar RatingNot Ratedout of funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MHCD |
|---|---|---|
| 01:03 ET | 300 | 11.29 |
| 03:23 ET | 200 | 11.28 |
| 03:39 ET | 1800 | 11.29 |
| 03:41 ET | 300 | 11.29 |
| US Equity | 75.4% |
|---|---|
| Int'l Equity | 15.1% |
| CDN Equity | 8.2% |
| Cash | 1.3% |
| Fixed Income | 0 |
| Other | 0 |
| Healthcare | 87.4% |
|---|---|
| Real Estate | 6.7% |
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 76.4% |
|---|---|
| Canada | 8.3% |
| Europe | 2.9% |
| Africa | 0 |
| Latin America | 0 |
| Asia/Oceania | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 6.4% | -3.17% | $9.4M |
UnitedHealth Group Inc | Long | 5.2% | 0.00% | $7.6M |
Merck & Co Inc | Long | 5.1% | 0.00% | $7.5M |
Chartwell Retirement Residences | Long | 5.1% | 0.00% | $7.4M |
AstraZeneca PLC | Long | 4.7% | 0.00% | $6.9M |
AbbVie Inc | Long | 4.6% | 0.00% | $6.7M |
Johnson & Johnson | Long | 4.6% | 0.00% | $6.7M |
Stryker Corp | Long | 4.3% | 0.00% | $6.3M |
Thermo Fisher Scientific Inc | Long | 4.1% | 0.00% | $5.9M |
Boston Scientific Corp | Long | 4.0% | 0.00% | $5.9M |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
|---|---|
Category | Sector Equity |
Sponsor | Middlefield Limited |
Inception | July 21, 2017 |
The investment objectives of the fund are to provide holders of Healthcare Units with: (a) stable monthly cash distributions; and (b) enhanced long-term total return through capital appreciation of the Healthcare investment portfolio through an investment strategy that focuses primarily on investing in dividend-paying securities of issuers operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the healthcare, life sciences and related industries.
| Total Net Assets | $163.3M |
|---|---|
| Shares Out. | 13.8M |
| Net Asset Value (NAV) | $11.28 |
| Prem/Discount to NAV | 0.01% |
| P/E Ratio | 27.4 |
| Dividend Yield | 5.31% |
| Dividend per Share | 0.60 CAD |
| Ex-Dividend Date | 03/27/2024 |
| Dividend Payment Date | 04/15/2024 |
| Beta | --- |
| Morningstar Investment Style | Sector Equity |
| Equity Style | Large Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.85% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 1.27% |